The association between lifetime polytobacco use and intention to quit among HIV-positive cigarette smokers

With the advent of antiretroviral (ARV) therapy, the effects of HIV pose a much smaller threat to mortality (Hessol et al., 2000; Lloyd-Smith et al., 2006). Scholars now attribute the majority of deaths among people living with HIV/AIDS (PLWH) to health risk behaviors, such as smoking (Helleberg et al., 2015). Among those adhering to ARV, the negative impact of smoking upon life expectancy is two times greater than HIV-related factors (Reddy et al., 2016). This is of major concern as nearly 54% of PLWH are reported to smoke cigarettes in the United States compared to 19% in the general population (Park et al., 2016; Mdodo et al., 2015; Pacek et al., 2014).

Source: Drug and Alcohol Dependence - June 19, 2018 Category: Addiction Authors: Micah J. Savin, Summer G. Frank-Pearce, Kim Pulvers, Damon J. Vidrine Source Type: research